1型糖尿病儿童糖尿病视网膜病变的发病率、危险因素和进展:一项来自新西兰区域中心的15年回顾性研究

IF 3.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Pediatric Diabetes Pub Date : 2024-06-28 eCollection Date: 2024-01-01 DOI:10.1155/2024/5893771
Thomas Winter, José G B Derraik, Craig A Jefferies, Paul L Hofman, James A D Shand, Geoffrey D Braatvedt, Stuti L Misra
{"title":"1型糖尿病儿童糖尿病视网膜病变的发病率、危险因素和进展:一项来自新西兰区域中心的15年回顾性研究","authors":"Thomas Winter, José G B Derraik, Craig A Jefferies, Paul L Hofman, James A D Shand, Geoffrey D Braatvedt, Stuti L Misra","doi":"10.1155/2024/5893771","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Diabetic retinopathy (DR) is the primary microvascular complication associated with diabetes. Evidence on DR prevalence among children in New Zealand is scarce. We examined DR rates and associated risk factors in youth with type 1 diabetes (T1D) aged <16 years receiving care from a regional diabetes service in January 2006-December 2020.</p><p><strong>Materials and methods: </strong>DR diagnosis followed the International Society for Pediatric and Adolescent Diabetes guidelines. The study included 646 participants; mean age (±SD) at T1D diagnosis was 7.4 ± 3.6 years, 47% were female, and 69% identified as NZ Europeans.</p><p><strong>Results: </strong>The initial DR screening occurred at a mean age of 12.6 ± 2.4 years and 5.2 ± 2.2 years after T1D diagnosis. At the first DR screen, 23.5% of participants (152/646) were diagnosed with DR: 69.1% (105/152) with minimal, 30.3% (46/152) with mild, and one moderate case (0.7%). Older age at diagnosis (<i>p</i>=0.029) and longer diabetes duration (<i>p</i>=0.015) were predictors of DR at first screen. Patients with at least one positive DR screen had a higher average HbA1c at their first screen (+2.6 mmol/mol; <i>p</i>=0.042). Overall, 55.6% (359/646) of patients had a positive DR screen, whose worst grade was mostly either minimal (58.2%) or mild (40.7%) DR, with only three moderate cases (0.8%) and one severe (0.3%). Children diagnosed with T1D before age 10 were 72% more likely to have DR than older children (<i>p</i> < 0.0001), and DR risk was 32% and 41% higher among Pacific children than NZ European (<i>p</i>=0.008) and Māori (<i>p</i>=0.014) children. Lastly, the only predictor of DR at discharge from paediatric services was HbA1c at the first screen (<i>p</i> < 0.0001).</p><p><strong>Conclusions: </strong>In this regional cohort of children with T1D, there was a high rate of low-grade DR overall and at first retinal screen, with an increasing rate until transfer to adult services. Our findings underscore the importance of ongoing DR screening, reducing glycaemic levels, and supporting vulnerable high-risk groups.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2024 ","pages":"5893771"},"PeriodicalIF":3.9000,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020911/pdf/","citationCount":"0","resultStr":"{\"title\":\"Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand.\",\"authors\":\"Thomas Winter, José G B Derraik, Craig A Jefferies, Paul L Hofman, James A D Shand, Geoffrey D Braatvedt, Stuti L Misra\",\"doi\":\"10.1155/2024/5893771\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Diabetic retinopathy (DR) is the primary microvascular complication associated with diabetes. Evidence on DR prevalence among children in New Zealand is scarce. We examined DR rates and associated risk factors in youth with type 1 diabetes (T1D) aged <16 years receiving care from a regional diabetes service in January 2006-December 2020.</p><p><strong>Materials and methods: </strong>DR diagnosis followed the International Society for Pediatric and Adolescent Diabetes guidelines. The study included 646 participants; mean age (±SD) at T1D diagnosis was 7.4 ± 3.6 years, 47% were female, and 69% identified as NZ Europeans.</p><p><strong>Results: </strong>The initial DR screening occurred at a mean age of 12.6 ± 2.4 years and 5.2 ± 2.2 years after T1D diagnosis. At the first DR screen, 23.5% of participants (152/646) were diagnosed with DR: 69.1% (105/152) with minimal, 30.3% (46/152) with mild, and one moderate case (0.7%). Older age at diagnosis (<i>p</i>=0.029) and longer diabetes duration (<i>p</i>=0.015) were predictors of DR at first screen. Patients with at least one positive DR screen had a higher average HbA1c at their first screen (+2.6 mmol/mol; <i>p</i>=0.042). Overall, 55.6% (359/646) of patients had a positive DR screen, whose worst grade was mostly either minimal (58.2%) or mild (40.7%) DR, with only three moderate cases (0.8%) and one severe (0.3%). Children diagnosed with T1D before age 10 were 72% more likely to have DR than older children (<i>p</i> < 0.0001), and DR risk was 32% and 41% higher among Pacific children than NZ European (<i>p</i>=0.008) and Māori (<i>p</i>=0.014) children. Lastly, the only predictor of DR at discharge from paediatric services was HbA1c at the first screen (<i>p</i> < 0.0001).</p><p><strong>Conclusions: </strong>In this regional cohort of children with T1D, there was a high rate of low-grade DR overall and at first retinal screen, with an increasing rate until transfer to adult services. Our findings underscore the importance of ongoing DR screening, reducing glycaemic levels, and supporting vulnerable high-risk groups.</p>\",\"PeriodicalId\":19797,\"journal\":{\"name\":\"Pediatric Diabetes\",\"volume\":\"2024 \",\"pages\":\"5893771\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2024-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020911/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Diabetes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2024/5893771\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2024/5893771","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:糖尿病视网膜病变(DR)是糖尿病的主要微血管并发症。关于新西兰儿童中DR患病率的证据很少。我们检查了青少年1型糖尿病(T1D)患者的DR率和相关危险因素。材料和方法:DR诊断遵循国际儿科和青少年糖尿病协会指南。该研究包括646名参与者;T1D诊断的平均年龄(±SD)为7.4±3.6岁,47%为女性,69%为新西兰欧洲人。结果:首次DR筛查发生在T1D诊断后的平均年龄为12.6±2.4岁和5.2±2.2岁。在第一次DR筛查中,23.5%的参与者(152/646)被诊断为DR: 69.1%(105/152)为轻度,30.3%(46/152)为轻度,1例中度(0.7%)。诊断年龄较大(p=0.029)和糖尿病病程较长(p=0.015)是首次筛查时DR的预测因子。至少有一次DR筛查阳性的患者在第一次筛查时平均HbA1c较高(+2.6 mmol/mol;p = 0.042)。总体而言,55.6%(359/646)患者的DR筛查呈阳性,其最差级别大多为轻度(58.2%)或轻度(40.7%)DR,只有3例中度(0.8%)和1例重度(0.3%)。10岁前诊断为T1D的儿童患DR的可能性比大一点的儿童高72% (p < 0.0001),太平洋儿童患DR的风险比新西兰欧洲儿童高32%和41% (p=0.008)和Māori儿童(p=0.014)。最后,第一次筛查时的糖化血红蛋白是儿科服务出院时DR的唯一预测因子(p < 0.0001)。结论:在这个区域性的T1D儿童队列中,总体上有很高的低级别DR率,并且在最初的视网膜筛查中,直到转移到成人服务中,这一比例一直在增加。我们的研究结果强调了持续进行DR筛查、降低血糖水平和支持易感高危人群的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand.

Aims: Diabetic retinopathy (DR) is the primary microvascular complication associated with diabetes. Evidence on DR prevalence among children in New Zealand is scarce. We examined DR rates and associated risk factors in youth with type 1 diabetes (T1D) aged <16 years receiving care from a regional diabetes service in January 2006-December 2020.

Materials and methods: DR diagnosis followed the International Society for Pediatric and Adolescent Diabetes guidelines. The study included 646 participants; mean age (±SD) at T1D diagnosis was 7.4 ± 3.6 years, 47% were female, and 69% identified as NZ Europeans.

Results: The initial DR screening occurred at a mean age of 12.6 ± 2.4 years and 5.2 ± 2.2 years after T1D diagnosis. At the first DR screen, 23.5% of participants (152/646) were diagnosed with DR: 69.1% (105/152) with minimal, 30.3% (46/152) with mild, and one moderate case (0.7%). Older age at diagnosis (p=0.029) and longer diabetes duration (p=0.015) were predictors of DR at first screen. Patients with at least one positive DR screen had a higher average HbA1c at their first screen (+2.6 mmol/mol; p=0.042). Overall, 55.6% (359/646) of patients had a positive DR screen, whose worst grade was mostly either minimal (58.2%) or mild (40.7%) DR, with only three moderate cases (0.8%) and one severe (0.3%). Children diagnosed with T1D before age 10 were 72% more likely to have DR than older children (p < 0.0001), and DR risk was 32% and 41% higher among Pacific children than NZ European (p=0.008) and Māori (p=0.014) children. Lastly, the only predictor of DR at discharge from paediatric services was HbA1c at the first screen (p < 0.0001).

Conclusions: In this regional cohort of children with T1D, there was a high rate of low-grade DR overall and at first retinal screen, with an increasing rate until transfer to adult services. Our findings underscore the importance of ongoing DR screening, reducing glycaemic levels, and supporting vulnerable high-risk groups.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pediatric Diabetes
Pediatric Diabetes 医学-内分泌学与代谢
CiteScore
6.60
自引率
14.70%
发文量
141
审稿时长
4-8 weeks
期刊介绍: Pediatric Diabetes is a bi-monthly journal devoted to disseminating new knowledge relating to the epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes in childhood and adolescence. The aim of the journal is to become the leading vehicle for international dissemination of research and practice relating to diabetes in youth. Papers are considered for publication based on the rigor of scientific approach, novelty, and importance for understanding mechanisms involved in the epidemiology and etiology of this disease, especially its molecular, biochemical and physiological aspects. Work relating to the clinical presentation, course, management and outcome of diabetes, including its physical and emotional sequelae, is considered. In vitro studies using animal or human tissues, whole animal and clinical studies in humans are also considered. The journal reviews full-length papers, preliminary communications with important new information, clinical reports, and reviews of major topics. Invited editorials, commentaries, and perspectives are a regular feature. The editors, based in the USA, Europe, and Australasia, maintain regular communications to assure rapid turnaround time of submitted manuscripts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信